Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 163

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trials

Open access
Chamberlain, M., Soffietti, R., Raizer, J., Ruda, R., Brandsma, D., Boogerd, W., Taillibert, S., Groves, M. D., Le Rhun, E., Junck, L., van den Bent, M., Wen, P. Y., Jaeckle, K. A. · 2014 · Neuro-Oncology

Abstract

Purpose.To date, response criteria and optimal methods for assessment of outcome have not been standardized in patients with leptomeningeal metastasis (LM). Methods.A Response Assessment in Neuro-Oncology working group of experts in LM critically reviewed published literature regarding randomized clinical trials (RCTs) and trial design in patients with LM.Results.A literature review determined that 6 RCTs regarding the treatment of LM have been published, all of which assessed the response to intra-CSF based chemotherapy.Amongst these RCTs, only a single trial attempted to determine whether intra-CSF chemotherapy was of benefit compared with systemic therapy.Otherwise, this pragmatic question has not been formally addressed in patients with solid cancers and LM.The methodology of the 6 RCTs varied widely with respect to pretreatment evaluation, type of treatment, and response to treatment.Additionally there was little uniformity in reporting of treatment-related toxicity.One RCT suggests no advantage of combined versus single-agent intra-CSF chemotherapy in patients with LM.No specific intra-CSF regimen has shown superior efficacy in the treatment of LM, with the exception of liposomal cytarabine in patients with lymphomatous meningitis.Problematic with all RCTs is the lack of standardization with respect to response criteria.There was considerable variation in definitions of response by clinical examination, neuroimaging, and CSF analysis. Conclusion.Based upon a review of published RCTs in LM, there exists a significant unmet need for guidelines for evaluating patients with LM in clinical practice as well as for response assessment in clinical trials.The term "leptomeningeal metastasis" (LM), also known as neoplastic meningitis, refers to involvement of the cerebrospinal fluid (CSF) and leptomeninges (pia and arachnoid) by any solid tumor or hematologic malignancy.When caused by systemic cancer, LM is often called carcinomatous meningitis or meningeal carcinomatosis and is reported in 4% -15% of patients with cancer. 1 -13 Lymphomatous or leukemic meningitis occurs in 5%-15% of patients with lymphoma or leukemia.1 -13 LM is the third most common metastatic complication affecting the central nervous system (CNS) after brain metastases and epidural spinal cord compression, with 7000-9000 new cases diagnosed annually in the United States. 1 -13 In decreasing order, the most

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/neuonc/nou089

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 163

Metadata

Authors
Chamberlain, M., Soffietti, R., Raizer, J., Ruda, R., Brandsma, D., Boogerd, W., Taillibert, S., Groves, M. D., Le Rhun, E., Junck, L., van den Bent, M., Wen, P. Y., & Jaeckle, K. A.
Venue
Neuro-Oncology
Published
2014-05-27
Volume
16
Issue
9
Pages
1176-1185
ISSN
  • 1522-8517 (ISSN-L)
  • 1523-5866
OpenAlex
W2171926883
Cited by
163
References
1
FWCI
14.54
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trials. https://app.cochat.ai/papers/10.1093/neuonc/nou089
The paper
Chamberlain, M., Soffietti, R., Raizer, J., Ruda, R., Brandsma, D., Boogerd, W., Taillibert, S., Groves, M. D., Le Rhun, E., Junck, L., van den Bent, M., Wen, P. Y., & Jaeckle, K. A. (2014). Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trials. Neuro-Oncology. https://doi.org/10.1093/neuonc/nou089

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.